✦ LIBER ✦

Who should receive a 5-HT3 antagonist?

✍ Scribed by Kaye, S.B.; Khayat, David; Aapro, M.; Diehl, V.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

62 Who should receive adjuvant treatment

✍ A. Goldhirsch 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 153 KB

5HT3 receptor antagonists

✍ A.T. Hindle 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 914 KB

LAS 30451: A novel 5-HT3 antagonist

✍ Martin, M.; Rosell, R.; Guillem, V.; Diaz-Rubio, E.; Moreno, I.; Soriano, V.; Fe 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Who should receive EGFR tyrosine-kinase

✍ Helena A Yu; Gregory J Riely 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 120 KB

5-HT 3 antagonists under development

✍ Chong, Youhoon; Choo, Hyunah 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 442 KB

Ondansetron, a 5-HT3 antagonist, improve

✍ P. Sirota; T. Mosheva; H. Shabtay; N. Giladi; A.D. Korcyn 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 163 KB